Nutrition, sleep, emotional wellbeing and wellness services: check the evidence before choosing claims, research or procurement materials.
Check claims, applicable populations and evidence gaps for medical and consumer health products. We also propose evidence dossiers that procurement agents can read and compare, with human review. Scope and pricing are agreed for each task.
Choose the deliverable you need
Inspect the value and deliverables, then agree scope, review and fees.
01 · FOCUSED
Health-claim appraisal
Do ingredient, mechanism or category studies support this product?
Core valueCheck whether ingredient studies support the actual product or service claim.
What you receiveDefine what the claim is supported by and where evidence is missing.
Claim, source and applicability table
Product-version and study-population differences
Evidence gaps and priority checks
Human-readable report and CSV; findings may support, partly support or not support a claim.
How fees workQuoted by product version, claim count and review scope
Agree start and delivery milestones after scoping; a claim may be unsupported, and fees buy the appraisal work.
Scope limits
Excludes efficacy certification, advertising legal review and product trials.
Amounts are proposed references or examples. Formal quotes depend on inputs, questions, professional review and acceptance scope. Agree updates separately; the same work is not charged twice.
FEATURED SERVICE · MEDICAL EVIDENCE
When agents help people choose, what makes your product or service credible?
Turn health claims into verifiable purchase information and measure agent discovery, enquiries and paid conversion. Inspect the evidence delivery and Libaorui pilot protocol.
Do those ingredient papers support the product you actually sell?
You will receive
Checkable deliverables: claim–source–applicability table, gaps and a staged study plan. Quoted by scope, without positive-result or sales guarantees.
Explore the scope
Map formula, finished version, amounts, duration and users to the claim. Then decide whether to narrow wording, obtain records or study the finished product.
You have positive reviews. Which users does this specific version help?
You will receive
Checkable deliverables: product/service mapping, measurement and comparison framework, permissions and adverse-feedback paths. Support is not automatically disease treatment.
Explore the scope
Define app/course/service version, content, guidance and actual use dose. Separate experience, behaviour and support outcomes, including adverse feedback and professional-support boundaries.
When a customer asks an agent to compare products, can each selling point be traced to evidence?
You will receive
Illustrative JSON fields, a readable explanation, claim-to-source links, review and version records. Evidence comparison and transaction authority remain separate: human review precedes a separately authorised purchase.
Explore the scope
Brands can plan a dossier readable by people and machines; platforms and businesses can plan an evidence comparison of supplier claims. The proposed scope includes product versions, populations, health outcomes, negative and uncertain findings, permissions and update triggers. This is a deliverable plan and demonstration, quoted by scope.
A development or access discussion is approaching. Which evidence gap should the next research budget address?
You will receive
A claim-to-source table and prioritized evidence questions, or a verifiable version and change log. Favorable, unfavorable and uncertain findings are retained.
Explore the scope
Pharmaceutical teams can assess evidence for one indication and comparator, or maintain an existing product baseline. Pilot references: CNY 50,000–200,000 for a gap package and CNY 200,000–1,000,000 or more for annual maintenance. Baseline construction and additional indications are agreed separately.
You have extensive technical materials. How far can a clinical claim go, and which sources are affected by a product change?
You will receive
A claim-to-evidence table, product-difference matrix and source package, or updates aligned with product versions, for the company’s further professional review.
Explore the scope
Device teams first separate material, animal and human evidence and check product differences; an existing evaluation baseline can then be maintained. Pilot references: CNY 50,000–200,000 for a literature-evaluation module and CNY 200,000–1,000,000 or more for annual maintenance. Necessary trials and regulatory-responsibility review are confirmed separately.
A delivery deadline is approaching. What can be handed over, how will the files fit your workflow, and how will quality be checked?
You will receive
Handover-ready search and screening records, question and review logs, or task outputs and remaining support hours. Clinical execution remains with the agreed responsible parties.
Explore the scope
CROs can commission a search-and-screening package or agree support hours for recurring methods, quality and handover questions. Pilot references: CNY 50,000–200,000 per module; annual capacity from CNY 240,000. Scheduling, response terms, concurrency and actual personnel must be confirmed first.
Review study objectives, eligibility, locations, status and reported results, then identify questions for the clinical team.
Scope & access conditions
Sponsors or investigators submit the records. A listing is not government approval of safety or effectiveness, or a determination that you should participate.
